Atlas Trials

A Pharmacokinetic Study of JKB-122 Tablets Compared to Capsule

Clinical trial NCT04313205 · UNKNOWN

Trial details

NCT number
NCT04313205
Sponsor
TaiwanJ Pharmaceuticals Co., Ltd
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Autoimmune Hepatitis
Start date
2020-08-01
Primary completion
2020-12-01
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.